Pharmafile Logo
Pharmafocus logo
Advanced Search

Diabetes

Showing 15 posts of 19 posts found.

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026
Research and Development Diabetes, Ondibta, Sandoz

Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …

News

MetP Pharma releases positive data on intranasal semaglutide administration

July 22, 2025
Research and Development Diabetes, MetP Pharma, Neurology, Obesity, central nervous system, diabetes, obesity, peptides, semaglutide

MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering neuroactive peptides, particularly semaglutide, directly …

News

Amarna Therapeutics and NorthX Biologics collaborate to advance gene therapy for type 1 diabetes

July 10, 2025
Mergers and Acquisitions, Research and Development Amarna Therapeutics, Diabetes, Immunology, NorthX Biologics, Type 1 diabetes, gene therapy, immune-mediated diseases

Amarna Therapeutics and NorthX Biologics have finalised an agreement to accelerate the development of Nimvec AM510, a gene therapy targeting …

News
money-2180330_960_720

Ciloa secures €6.5m from French government to advance obesity and T2 diabetes therapy

July 9, 2025
Research and Development Ciloa, Diabetes, France 2030, Obesity, adiponectin, funding, obesity, type 2 diabetes

French biotech company, Ciloa, has received €6.5m in funding through France 2030 to advance its lead candidate, APN-sEV, targeting obesity …

News
handshake_2

AOTI achieves broad market access in Germany for diabetic foot ulcer therapy

June 23, 2025
Market Access, Medical Communications, Sales and Marketing AOTI, Diabetes, European pharma market, German pharma market, Wound Healing, diabetic foot ulcers, market access, positive recommendation

AOTI, focused on solutions for severe and chronic wounds, has announced that its unique topical wound oxygen (TWO2) therapy has …

News

Teen band 1Type releases single to raise awareness of type 1 diabetes

May 30, 2025
Medical Communications, Medical Education 1Type, Diabetes, Rise Up, Sanofi, Stagecoach Performing Art, autoimmune type 1 diabetes

Four teenagers living with autoimmune type 1 diabetes (aT1D) have released a single aimed at raising awareness of the condition …

News
handshake_2

AOTI diabetic foot care therapy to be used by NHS

April 23, 2025
Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …

News

Roche gains CE Mark for AI glucose monitoring system for diabetes management

July 9, 2024
Medical Communications AI, Diabetes, Roche, diabetes, glucose monitoring

Roche has announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution.

News

Vertex shares results from phase 1/2 trial of type 1 diabetes treatment

June 24, 2024
Research and Development Diabetes, Vertex pharmaceuticals, clinical trial, diabetes

Vertex Pharmaceuticals has announced new data from its phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated …

News

Eli Lilly increases manufacturing investment to $9bn at new Indiana site

May 28, 2024
Manufacturing and Production Diabetes, Eli Lilly, Indiana, investment, manufacturing

Eli Lilly has announced that it has more than doubled its investment at its Lebanon, Indiana, US manufacturing site with …

News

CHMP recommends Novo Nordisk’s Awiqli for diabetes treatment

March 22, 2024
Medical Communications CHMP, Diabetes, Novo Nordisk, diabetes

Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended …

News

Roche shares data on novel solution for continuous glucose monitoring

March 8, 2024
Research and Development Diabetes, Medical device, Roche, continuous glucose monitoring, diabetes

Roche has shared the latest data on its novel solution for continuous glucose monitoring (CGM), including a CGM sensor and …

News

MHRA approves Mounjaro for diabetes and weight management

January 26, 2024
Medical Communications Diabetes, MHRA, Mounjaro, weight management

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it has approved a four-dose version of the diabetes …

News

Novo Nordisk shares positive results from COMBINE 3 phase 3a trial

January 10, 2024
Research and Development Diabetes, IcoSema, Novo Nordisk, clinical trial, diabetes

Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weeklly IcoSema, a fixed-ration combination treatment …

News
national-cancer-institute-l8twzt4ccvq-unsplash_1

Eli Lilly launches digital healthcare process

January 5, 2024
Medical Communications Diabetes, Eli Lilly, Obesity, diabetes, obesity

Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026